Member Info for CHELSEA7

Bermuda, morning, just looking at the management positions on the Scancell website which you posted and am pretty sure 7 out of the 9 were RNSed, so not without prescedent.

Bermuda, thanks for that. Tell you the truth I havent looked at the website for some time. That is some investment on the scientific side and we trust and hope that translates into a commercial deal/s

Bermuda,

Sorry you have lost me there, IR?

"but so far nothing has happened to provide any additional support on the commercial/business management/strategy side (including IR)"........how do we know that?

No conspiracy I can see either, but he hasn"t been given an official title for no reason.

Ruck, yeah it does sound dismissive, why do you think then that Richard has left the potting shed to become CBO? Must be a reason IMHO.

WTP, Must be 10 years since my business days, but is it not the case that Chief ranks higher than Head of?

Ray/Ruck,

Something I do find strange which we have all mentioned a few times for various reasons, is that we RNS when we have a new CSO and indeed we had an RNS saying Lindy has taken over the role of CEO, so why do we not RNS when Richard takes over the role of CBO?

Surely there has to be a reason why he has been given that role at this time? Is it just to make Richard an "|insider" for any price sensitive news? which he may be privy to considering the size of his holding and knowledge of previous discussions.

My feelings entirely, some statement!!

I would have thought Richard has always had at least some involvement these past few years, interesting though at this time he has an official title Just perhaps looking positively any interest there might have been during his tenure has been reignited, so I agree with Bermuda and directingas an interesting development for the short term, and raises the prospect of news in that time frame.

Have a good weekend all.

With regard to the SP I think to see another Diggle buy at even 17p would at the least find a floor for the SP for now as we see a daily decline, not big volumes but very little buying pressure.

I think we got a good RNS monday and positive feedback on reactions to SCOV1 but that hasnt put a stop to this gradual fall.

Goodnight

Morning Ruck,

Yeah so was I.....................Tuesday................Last Week!!!!

C11, good post. Just IMO and listening to a few shareholders after the Interim Results there were obvious doubts as to our timelines leading to overall doubts as to whether we would ever commercialise Covidity at all compared to when we received the first person dosed.

Reading your post and the RNS restored any lost faith I had. With cases reaching new lows since 15th December I just wonder how much longer we will have to wait to hear that cancer trials are back on track? As a few others have noted there are several inflection points to come in the near term.

Morning All, just seen yesterdays RNS, lol, and much like my Sunday post delighted with the news therein.

Certainly closes the door on some idle speculation but as I said before could we not have released the main body of that to coincide with the Interims, it would certainly have closed off some harsh posts regarding the 16 patients and who knows could well have reduced some of the sell volume we saw. My only surprise this morning is that we did not finish on a blue day.

But, good news on a Monday morning, delighted with that and hoping to see us back to the early 20s very soon.

Morning Guys,

Ruck, as you posted..............""..To me, the excuse for the stalled recruitment given by the company is pretty lame. It seems there are major flaws in recruitment process.""

Well it certainly seems that way every time we declare a trial is recruiting we find difficulty finding patients who fit the criteria for the trial. However, with the Covidity trial and bearing that in mind I was delighted to hear we had enrolled the first 16 patients in what seemed little time.Again it seems to me we stopped recruitment at that point IMO to see how the Omicron variant was playing out and in circumstances such as these it would be helpful if the company would explain what and why they are doing, and whether they have changed the numbers they originally gave confidant we have enough patients to conclusively pass Phase 1 and then move on to a bigger Phase 2.

By not doing so this is just another example of how speculation becomes rife, when we could so easily be on the same page. Our ultimate aim is to move on to a Phase 2 as quickly as possible, with the onset of Omicron in S.Africa I do believe a change in Phase 2 numbers would be widely understood rather than allow speculation to grow in a very negative way......................communication? hasn"t been our strongest point has it !!!

Thanks for the posts Ray and Bermuda, I just feel perhaps that we should be grateful to have dosed the first 16 patients as the Omicron variant took hold.

Surely if the results prove up safety, which we all expect, it will set us up for a larger Phase 2 trial?? We certainly have the funds to do so. We certainly proved up safety with the SCIB1 trial all those years ago. As a result our trading change first fell fro 22/23 to 20/21.50 and now 18/20. Understandable IMHO

At 18.52, showing as a buy

For 40k

Be assured I put it to bed last week.

If anybody posted their hope was x,y or z who is anyone to query that. So we move forward....................good

Rising very slowly, up to 160k at 18.52 and over 18.21

AB, OBVIOUSLY if they felt the share was due a rise prior to the RNS they might have bought at 21p, what other reason could there be?

And as per my posts earlier and our umerous (too many) posts last week, you know the answer.

Good Morning AB

Well in retrospect it would have bee a bad trade, but many of us were hoping not to see the fall if circumstances had been different. Had that have been the case a buy at 21p would have been good business.

Oh for hindsight eh and as you say, lets see.